Mandate

Vinge has advised Apotea in connection with its listing on Nasdaq Stockholm

Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on November 26, 2024 and the first day of trading is December 6, 2024.

The offering price was SEK 58 per ordinary share, corresponding to a total market value for all ordinary shares in Apotea of approximately SEK 6 billion. The total value of the offering amounts to approximately SEK 1,880 million, provided that the overallotment option is exercised in full.

Apotea is Sweden’s leading online pharmacy by market share with the goal of becoming the largest pharmacy in Sweden and hence also in the Nordics. With the widest assortment on the market, low prices and quick deliveries, the company facilitates everyday life for its three million active customers.

Vinge’s team primarily consisted of Jesper Schönbeck, Amanda Knutsson, Anna Svensson, Lorin Arabi, Karin Karsten and Elias Kröger (Capital Markets and Public M&A), Victor Ericsson, Emelie Svanberg, Ellenor Eckerborn och Marcus Svärd (Corporate Tax), Sam Seddigh and Emil Lindwall (Employment), Helena Rosén Andersson and Hilda Ivarsson (Permits), Fredrika Hjelmberg, Mario Saad and Siri Blomberg (Commercial agreements, IT and GDPR), Ian Jonson (Intellectual Property) and Sofia Haggren (Financing).

Related

Vinge advises Röko AB (publ) in connection with the establishment of its MTN programme

Vinge has advised Röko AB (publ) ("Röko") on the establishment of a medium-term note programme (the "MTN Programme") with a framework amount of SEK 5 billion.
November 13, 2026

Vinge advises Telavox on the sale of its Nordic customer base to Telia

Vinge has advised Telavox AB (“Telavox”) on the sale of Telavox’s Nordic customer base for business services to Telia Company AB (“Telia”). The customer base comprises approximately 24,000 business customers and 325,000 end users in Sweden, Denmark, Finland, and Norway. The purchase price amounts to SEK 3.8 billion plus a potential additional earn-out.
November 13, 2026

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026